Keyphrases
Colon Cancer
100%
Adjuvant Chemotherapy
100%
Molecular Predictors
100%
Survival Prediction
100%
Microsatellite Instability-high (MSI-H)
100%
Transforming Growth Factor-β
75%
Tumor
75%
Activin Type II Receptor
75%
Loss of Heterozygosity
75%
5-year Survival
50%
Confidence Interval
50%
Fluorouracil
50%
Stage III Colon Cancer
50%
Relative Risk of Death
50%
Microsatellite Stable
50%
Cellular Level
25%
In Cancer
25%
Favorable Outcome
25%
Molecular Markers
25%
Tumor Tissue
25%
Outcome Prediction
25%
Mutated Genes
25%
P21Cip1
25%
Levamisole
25%
Fluoropyrimidine-based Chemotherapy
25%
Leucovorin
25%
Allelic Loss
25%
High-risk Stage II
25%
Chromosome 8p
25%
Chromosome 18q
25%
Stage II Colon Cancer
25%
Stable Stage
25%
Medicine and Dentistry
Neoplasm
100%
Adjuvant Chemotherapy
100%
Colon Carcinoma
100%
Microsatellite Instability
100%
Receptor
75%
Fluorouracil
75%
Cancer Growth Factor
75%
Cancer
75%
Allele
75%
Fibrinogen
75%
Heterozygosity
50%
Malignant Neoplasm
50%
Overall Survival
25%
Stage 3
25%
Protein P53
25%
Levamisole
25%
Folinic Acid
25%
Chromosome 8p
25%
Chromosome 18q
25%
Chromosome 17p
25%
Five-Year Survival Rate
25%
Cyclin Dependent Kinase Inhibitor 1
25%
Molecular Marker
25%
Biochemistry, Genetics and Molecular Biology
Colon
100%
Microsatellite Instability
100%
Allele
75%
Fluorouracil
75%
Fibrinogen
75%
Cancer Growth Factor
75%
Loss of Heterozygosity
50%
Microsatellite
50%
Genetic Marker
25%
Mutated Genes
25%
Overall Survival
25%
Survival Rate
25%
Chromosome 8p
25%
Chromosome 17p
25%
Chromosome 18q
25%
P53
25%
Immunology and Microbiology
Colon
100%
Microsatellite Instability
100%
Cancer Growth Factor
75%
Allele
75%
Fibrinogen
75%
Heterozygosity
50%
Genetic Marker
25%
Overall Survival
25%
Survival Rate
25%
Levamisole
25%
Chromosome 18q
25%
Chromosome 8p
25%
Chromosome 17p
25%
P53
25%
Veterinary Science and Veterinary Medicine
Cancer
100%
Colon Cancer
100%
Neoplasm
80%
Cancer Growth Factor
60%
P53
20%
Stage 3 Cancer
20%